Colgate-Palmolive Company DRC (CLm)

Buenos Aires


	Symbol		Exchange		Currency
	CLm		Buenos Aires		ARS	Delayed
	CL		NYSE		USD	Real-time
	CL		Mexico		MXN	Delayed
	1CL		Milan		EUR	Real-time
	CL		Xetra		EUR	Delayed
	CL		Frankfurt		EUR	Delayed
	CL		TradeGate		EUR	Delayed
	COLG34		B3		BRL	Delayed
	CL		Vienna		EUR	Real-time

Currency in ARS

39,750.00

+825.00(+2.12%)

Closed14/10

Fair Value

Day's Range

39,225.00

39,750.00

52 wk Range

20,000.00

48,000.00

CLm Income Statement

Featured here, the Income Statement (earnings report) for Colgate-Palmolive Company DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

15,693

16,471

17,421

17,967

19,457

Total Revenues Growth

+0.96%

+4.96%

+5.77%

+3.13%

+8.29%

Cost Of Revenues

6,357

6,454

7,046

7,719

8,130

Gross Profit

9,336

10,017

10,375

10,248

11,327

Gross Profit Growth

+0.8%

+7.29%

+3.57%

-1.22%

+10.53%

Gross Profit Margin %

59.49%

60.82%

59.55%

57.04%

58.22%

Other Operating Expenses, Total

5,692

6,229

6,562

6,666

7,385

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.43%	+9.43%	+5.35%	+1.58%	+10.79%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,616	6,093	6,477	6,625	7,237
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	76	136	85	41	148

Operating Income

3,644

3,788

3,813

3,582

3,942

Operating Income Growth

-3.06%

+3.95%

+0.66%

-6.06%

+10.05%

EBIT Margin %

23.22%

23%

21.89%

19.94%

20.26%

Net Interest Expenses

-145

-164

-100

-153

-232

Net Interest Expenses Growth

-1.4%

-13.1%

+39.02%

-53%

-51.63%

Interest Expense, Total

-192

-183

-117

-167

-287

Interest And Investment Income

47

19

17

14

55

Other Non Operating Expenses, Total

9

12

12

12

17

EBT, Excl. Unusual Items

3,508

3,636

3,725

3,441

3,727

Gain (Loss) On Sale Of Assets

-

-

-

47

-

Other Unusual Items, Total

-

-

-646

-389

-292

EBT, Incl. Unusual Items

3,301

3,647

3,087

2,660

3,392

EBT, Incl. Unusual Items Growth

-4.71%

+10.48%

-15.36%

-13.83%

+27.52%

EBT, Incl. Unusual Items Margin

21.03%

22.14%

17.72%

14.8%

17.43%

Income Tax Expense

774

787

749

693

937

Net Income to Company

2,527

2,860

2,338

1,967

2,455

Minority Interest

-160

-165

-172

-182

-155

Net Income

2,367

2,695

2,166

1,785

2,300

Net Income Growth

-1.38%

+13.86%

-19.63%

-17.59%

+28.85%

Net Income Margin %

15.08%

16.36%

12.43%

9.93%

11.82%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

2,367

2,695

2,166

1,785

2,300

Basic EPS - Continuing Operations

2.76

3.15

2.56

2.13

2.78

Basic EPS - Continuing Operations Growth

-0.05%

+14.16%

-18.51%

-16.74%

+30.25%

Diluted EPS - Continuing Operations

2.75

3.14

2.55

2.13

2.77

Diluted EPS - Continuing Operations Growth

0%

+14.18%

-18.79%

-16.47%

+30.05%

Basic Weighted Average Shares Outstanding

859.1

856.8

845

836.4

827.4

Diluted Weighted Average Shares Outstanding

861.1

859.3

848.3

838.8

829.2

Dividend Per Share

1.71

1.75

1.79

1.86

1.91

Dividend Per Share Growth

+3.01%

+2.34%

+2.29%

+3.91%

+2.69%

EBITDA

4,163

4,327

4,369

4,127

4,509

EBITDA Growth

-2.46%

+3.94%

+0.97%

-5.54%

+9.26%

EBITDA Margin %